Funding for the treatment of non-communicable diseases in Sub-Saharan Africa, including Type 1 diabetes, rheumatic and congenital heart disease, and sickle cell disease; monitoring changes to the Administration and focus of US humanitarian assistance programs
2026 · 2nd Quarter (Apr 1 - June 30)
MASS GENERAL BRIGHAM
Filed by WINNING STRATEGIES WASHINGTON.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 16, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- WINNING STRATEGIES WASHINGTON
- Client
- MASS GENERAL BRIGHAM
- Filing UUID
- b57f1b6e-a98d-42ca-bf06-7c6ad07b214e
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Funding for the treatment of non-communicable diseases in Sub-Saharan Africa including Type 1 diabetes, rheumatic and congenital heart disease, and sickle cell disease; monitoring changes to the Administration and focus of US humanitarian assistance programs
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.